HCP, Inc. (NYSE:HCP) Receives $36.78 Average Price Target from Analysts
HCP, Inc. (NYSE:HCP) has earned an average recommendation of “Buy” from the thirteen brokerages that are presently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 12 month price target among brokers that have covered the stock in the last year is $36.78.
A number of research firms have recently weighed in on HCP. Argus raised shares of HCP from a “hold” rating to a “buy” rating in a research note on Tuesday, September 10th. Morgan Stanley upped their price target on shares of HCP from $32.00 to $35.00 and gave the stock an “equal weight” rating in a research note on Tuesday, September 17th. ValuEngine downgraded shares of HCP from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. KeyCorp upped their price target on shares of HCP from $34.00 to $37.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 2nd. Finally, JPMorgan Chase & Co. raised shares of HCP from a “neutral” rating to an “overweight” rating and upped their price target for the stock from $35.00 to $38.00 in a research note on Tuesday, October 8th.
HCP opened at $32.25 on Tuesday. The stock has a fifty day moving average of $34.80 and a 200-day moving average of $34.01. The firm has a market capitalization of $15.87 billion, a P/E ratio of 17.72, a PEG ratio of 6.81 and a beta of 0.22. HCP has a 12-month low of $26.58 and a 12-month high of $37.93. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 1.01.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 19th. Shareholders of record on Monday, November 4th were given a dividend of $0.37 per share. This represents a $1.48 annualized dividend and a yield of 4.59%. The ex-dividend date of this dividend was Friday, November 1st. HCP’s payout ratio is 81.32%.
Institutional investors have recently bought and sold shares of the business. Quest Capital Management Inc. ADV acquired a new position in HCP during the third quarter worth $28,000. Bartlett & Co. LLC acquired a new position in HCP during the third quarter worth $36,000. NEXT Financial Group Inc increased its position in HCP by 181.3% during the second quarter. NEXT Financial Group Inc now owns 1,125 shares of the real estate investment trust’s stock worth $36,000 after buying an additional 725 shares during the last quarter. CSat Investment Advisory L.P. increased its position in HCP by 77.6% during the second quarter. CSat Investment Advisory L.P. now owns 1,165 shares of the real estate investment trust’s stock worth $37,000 after buying an additional 509 shares during the last quarter. Finally, Parallel Advisors LLC increased its position in HCP by 29.9% during the third quarter. Parallel Advisors LLC now owns 1,364 shares of the real estate investment trust’s stock worth $49,000 after buying an additional 314 shares during the last quarter. 95.80% of the stock is currently owned by hedge funds and other institutional investors.
HCP Company Profile
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
See Also: Treasury Bonds
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.